Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer

Published:2017-04 Issue:2 Volume:17 Page:91-99.e1
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Cinieri Saverio,Chan Arlene,Altundag Kadri,Vandebroek An,Tubiana-Mathieu Nicole,Barnadas Agusti,Dodyk Patricia,Lazzarelli Silvia,Botha Michiel,Rauch Daniel,Villanova Gustavo,Coskun Ugur

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2);Cardoso;Ann Oncol,2014

2. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2);Cardoso;Breast,2014

3. Combination versus sequential single agent chemotherapy for metastatic breast cancer;Dear;Cochrane Database Syst Rev,2013

4. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results;O'Shaughnessy;J Clin Oncol,2002

5. Gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment;Albain;J Clin Oncol,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer;Scientific Reports;2023-09-08

2. The prognosis and risk factors for capecitabine maintenance treatment in metastatic breast cancer: a retrospective comparative cohort study;Annals of Translational Medicine;2022-09

3. Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis;Future Science OA;2021-12

4. A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes;Frontiers in Oncology;2021-11-22

5. Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer;British Journal of Cancer;2021-09-03